Endometrial Leucocytes Around the Time of Embryo Implantation in Women Undergoing in IVF-ET
1 other identifier
observational
120
1 country
1
Brief Summary
Uterine natural killer (uNK) cells have been implicated to play a role in female reproductive performance. Serval studies showed an increased uNK cell density in the endometrium of women with reproductive failure. In this study, we wish to investigate the density and clustering of four different immune cells.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2019
CompletedFirst Posted
Study publicly available on registry
September 6, 2019
CompletedStudy Start
First participant enrolled
September 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJanuary 23, 2020
January 1, 2020
3.3 years
August 27, 2019
January 21, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
immune cell counting
The counting method will be performed according to an agreed and published standardized protocol by a multicenter working group designed to reduce variance of results between centres. Ten images of 40X magnification fields will be analyzed for each sample. The first field to be captured should be selected at random, ensuring that it contained the luminal epithelial border. Subsequent fields should be obtained by moving one field to the left or right of the original field, keeping the luminal epithelial border in view.
up to 2 months
Quantification of endometrial immune cells spatial distribution
In each 200 times under the microscope vision, based on the X and Y position of each single cell which InForm system could provide, the relative spatial distribution of each individual endometrial immune cell will be considered as a bivariate point pattern
up to 2 months
Study Arms (1)
women who are undergoing frozen embryo transfer
endometrial biopsy will be done one cycle before the frozen embryo transfer
Interventions
. Endometrial samples are obtained using a biopsy catheter as follows: the Pipette is inserted through the cervical os and advanced gently until resistance is felt. The inner piton of the device is then withdrawn to create suction, and the endometrial sample is obtained by moving the pipette up and down approximately 2-3 cm within the uterine cavity. The device is rotated 360° to ensure adequate coverage of the area.
Eligibility Criteria
Women undergoing frozen embryo transfer.
You may qualify if:
- Women undergoing frozen embryo transfer.
You may not qualify if:
- Women older than 40 years
- Women who have any uterine anomaly or intrauterine pathology such as:
- Endometrial polyp or/ and Large fibroid with a diameter \>4 cm
- Visible hydrosalpinx on transvaginal ultrasound scans
- BMI \>35
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Biospecimen
endometrial samples will be stored
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaoyan Chen, PhD
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
August 27, 2019
First Posted
September 6, 2019
Study Start
September 15, 2019
Primary Completion
December 31, 2022
Study Completion
December 31, 2023
Last Updated
January 23, 2020
Record last verified: 2020-01